Osaic Holdings’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.77K | Buy |
3,694
+1,076
| +41% | +$1.39K | ﹤0.01% | 6165 |
|
|
2025
Q1 | $2.11K | Sell |
2,618
-1,076
| -29% | -$867 | ﹤0.01% | 6448 |
|
|
2024
Q4 | $5.09K | Sell |
3,694
-78
| -2% | -$107 | ﹤0.01% | 6085 |
|
|
2024
Q3 | $3.92K | Hold |
3,772
| – | – | ﹤0.01% | 6185 |
|
|
2024
Q2 | $6.46K | Sell |
3,772
-182
| -5% | -$312 | ﹤0.01% | 5944 |
|
|
2024
Q1 | $9.43K | Buy |
3,954
+564
| +17% | +$1.35K | ﹤0.01% | 5698 |
|
|
2023
Q4 | $11.3K | Sell |
3,390
-425
| -11% | -$1.41K | ﹤0.01% | 5739 |
|
|
2023
Q3 | $14.3K | Buy |
3,815
+2,005
| +111% | +$7.5K | ﹤0.01% | 5703 |
|
|
2023
Q2 | $7.73K | Hold |
1,810
| – | – | ﹤0.01% | 6044 |
|
|
2023
Q1 | $12.4K | Hold |
1,810
| – | – | ﹤0.01% | 5821 |
|
|
2022
Q4 | $14.5K | Buy |
1,810
+1,726
| +2,055% | +$13.8K | ﹤0.01% | 5741 |
|
|
2022
Q3 | $1K | Hold |
84
| – | – | ﹤0.01% | 6864 |
|
|
2022
Q2 | $1K | Sell |
84
-487
| -85% | -$5.8K | ﹤0.01% | 6950 |
|
|
2022
Q1 | $8K | Sell |
571
-966
| -63% | -$13.5K | ﹤0.01% | 6215 |
|
|
2021
Q4 | $24K | Buy |
1,537
+419
| +37% | +$6.54K | ﹤0.01% | 5640 |
|
|
2021
Q3 | $17K | Buy |
1,118
+373
| +50% | +$5.67K | ﹤0.01% | 5860 |
|
|
2021
Q2 | $10K | Buy |
745
+306
| +70% | +$4.11K | ﹤0.01% | 6024 |
|
|
2021
Q1 | $6K | Buy |
439
+236
| +116% | +$3.23K | ﹤0.01% | 6022 |
|
|
2020
Q4 | $4K | Sell |
203
-842
| -81% | -$16.6K | ﹤0.01% | 5763 |
|
|
2020
Q3 | $19K | Buy |
1,045
+500
| +92% | +$9.09K | ﹤0.01% | 4912 |
|
|
2020
Q2 | $10K | Sell |
545
-4,620
| -89% | -$84.8K | ﹤0.01% | 5127 |
|
|
2020
Q1 | $82K | Buy |
+5,165
| New | +$82K | ﹤0.01% | 3612 |
|